Sodium Butyrate vs Tributyrin: An Honest Comparison of Butyrate Forms (2026)
Sodium butyrate is butyric acid bound to sodium, which dissolves and releases butyrate early in digestion. Tributyrin is three butyrate molecules attached to a glycerol backbone, so it needs pancreatic lipase to cut them free. Both raise butyrate levels. Neither has been proven superior in a human head-to-head trial.
This is the two-form matchup. Our full butyrate supplement guide compares all three forms and grades every benefit claim by species.
Key takeaways
- Sodium butyrate is a salt, tributyrin is a triglyceride
- Tributyrin needs lipase, so timing depends on fat digestion
- Human data on butyrate outcomes is genuinely mixed
- Most delivery claims come from animal or lab models
- Smell and taste differ sharply between the forms
What's the actual difference between sodium butyrate and tributyrin?
Both deliver butyrate, a short-chain fatty acid your gut bacteria already make when they ferment fiber. The chemistry of how that butyrate is packaged is where they split.
Sodium butyrate is butyric acid paired with sodium. It's a salt, it's water-soluble, and it comes apart quickly once it hits fluid. That's why so many sodium butyrate products are sold as enteric-coated capsules or microencapsulated beads: the raw powder would release most of its payload before it got anywhere interesting.
Tributyrin is an oil. Three butyrate molecules sit on a glycerol backbone, exactly like any dietary fat, and pancreatic lipase has to cleave them off before the butyrate is free. That extra step is the entire pitch: slower release, delivered further down.
There's a third option you'll see less often, which is butyrate bound to an amino acid instead of a mineral or a fat. That's the form we use, and I'll get to why below.
If you want the broader picture of what butyrate does before comparing forms, I wrote a longer butyrate supplement guide that covers the mechanism in more depth.
Does tributyrin really survive the stomach?
This is the claim you'll see on nearly every tributyrin label, and it deserves a harder look.
A 2023 human crossover trial in men with overweight or obesity ran a nice experiment on the way to its main result. Before dosing anyone, the researchers put tributyrin through a validated model of the stomach and small intestine. Tributyrin was rapidly cleaved in the gastric compartment, not the small intestine (van Deuren et al., 2023).
Plain tributyrin came apart early. Only when the researchers esterified the butyrate with long-chain fatty acids did release shift downstream into the small intestine.
So the "survives the stomach intact" story is doing more work in ad copy than in the lab model. That doesn't make tributyrin bad. It means the delivery advantage is more conditional than the label implies.
Plain tributyrin got cleaved in the stomach compartment, not the small intestine. The label says otherwise.
Most of the flattering tributyrin research is preclinical. Tributyrin supported intestinal barrier markers and tight junction proteins in mice exposed to alcohol (Cresci et al., 2017), in mice given antibiotics (Yang et al., 2023), and again in mice alongside human intestinal cell work (Siddiqui et al., 2024). Earlier mouse work paired it with a probiotic and saw similar patterns (Cresci et al., 2013).
Rodents are not small people. Their gut transit, microbiome, and fat digestion all differ from ours. This literature is full of mouse findings quoted as human fact, and the gut-supplement category is one of the worst offenders.
The one genuine head-to-head comparison of forms I could find compared microencapsulated sodium butyrate against tributyrin in black sea bream (Ullah et al., 2025). Interesting for aquaculture. Not something I'd build a human recommendation on.
What has oral butyrate actually been tested on in humans?
Here's the section most butyrate brands skip. Everything below involved participants who were patients under medical care, studied for medical outcomes, so read it as background on the molecule rather than as anything about a daily wellness drink.
The honest summary: results are all over the map.
| Study population | Form | Result |
|---|---|---|
| Adults with type 1 diabetes | Sodium butyrate | Fecal butyrate rose. Immune measures unchanged. |
| Children with IBD | Sodium butyrate | No benefit over placebo at 12 weeks. |
| Adults with type 2 diabetes | Sodium butyrate | Mostly null. Some unfavorable lipid shifts. |
| Adults with fatty liver disease | Sodium vs calcium butyrate | Primary endpoint unchanged in both arms. |
| Adults with IBD | Microencapsulated sodium butyrate | Shifted gut bacteria toward SCFA producers. |
| Children with obesity | Sodium butyrate | Positive across several measures. |
The type 1 diabetes trial is the most useful one for settling a basic question (de Groot et al., 2020). Oral butyrate measurably raised fecal butyrate and propionate, which confirms the stuff arrives. It just didn't move the immune outcomes they were looking for.
The pediatric IBD trial found nothing over placebo (Pietrzak et al., 2022). The type 2 diabetes trial was largely null and flagged some unfavorable cholesterol movement worth knowing about (Khosravi et al., 2022).
A 2025 trial compared sodium butyrate against calcium butyrate in 181 adults with fatty liver disease and found no change in the primary endpoint for either salt (Mitrović et al., 2025). That's the closest thing we have to a form-versus-form human comparison, and it came back a tie at zero.
On the encouraging side, microencapsulated sodium butyrate shifted the gut microbiome toward butyrate-producing bacteria in adults with IBD (Facchin et al., 2020), and a pediatric obesity trial reported positive results across several markers (Coppola et al., 2022).
Six trials, three roughly positive, three roughly null. Anyone selling you certainty about butyrate forms is selling you something the literature hasn't earned yet.
What about GLP-1? Doesn't butyrate boost it?
I get this question constantly, and I want to be careful here because our own category is sloppy about it.
The GLP-1 story for butyrate is preclinical. In rodent and cell studies, butyrate stimulates L-cells in the intestinal lining, and those are the cells that release GLP-1. That's the proposed mechanism, and it's a reasonable one.
What we don't have is a human study showing butyrate raises GLP-1. The 2023 trial I mentioned earlier is the sharpest test of it: butyrate-enriched triglycerides did raise circulating butyrate in men with overweight or obesity, and GLP-1 was measured as a named secondary outcome. It did not change (van Deuren et al., 2023).
Circulating butyrate went up. GLP-1 stayed flat. That's the honest state of the human evidence.
So when you see a butyrate product claiming it boosts your GLP-1, that claim is running on mouse data. I'd rather tell you that than let you find out from a Reddit thread. For the fuller version, see butyrate and GLP-1 and our primer on what GLP-1 actually is.
Why does butyrate smell so bad, and does the form fix it?
Butyric acid is the compound behind the smell of rancid butter and parmesan left in a hot car. It's genuinely unpleasant, and it's the single biggest reason butyrate supplements are sold as capsules you swallow fast.
The form changes the experience a lot.
Sodium butyrate powder is the worst offender by smell. Tributyrin is an oil, so the butyrate is chemically tied up until digestion frees it, which mutes the odor considerably (softgels help too).
Binding butyrate to an amino acid also blunts it. Nothing makes it disappear entirely. Anyone promising a completely neutral butyrate product is overselling.
What about L-lysine butyrate, the form in Ozzi?
We use L-lysine butyrate, which binds butyrate to the amino acid L-lysine rather than to sodium or a glycerol backbone. Ozzi has 500mg per stick.
Two practical reasons drove that pick. It handles better in a cold-water drink stick than sodium butyrate does, and it carries no added sodium load.
Now the part I'm obligated to say plainly: there are zero human randomized trials on L-lysine butyrate specifically. Not one. Every claim about it being superior to other forms, including any you might infer from me, is currently unproven.
What I can tell you honestly is that butyrate is the primary energy source for the cells lining your colon, and that we pair it with chicory root inulin, a prebiotic fiber that feeds butyrate-producing bacteria. Direct butyrate plus fuel for your own bacteria to make more. That combination is the design logic, and you can read more about the food-first version in how to increase butyrate naturally.
Which butyrate form should you actually pick?
Given how thin the comparative evidence is, I'd choose on practical grounds rather than on a delivery claim.
Pick tributyrin if you want a capsule or softgel, you're sensitive to smell, and you don't mind that most of its supporting research is preclinical.
Pick sodium butyrate if you want the form with the most human trial exposure, and look for microencapsulated or enteric-coated versions since those are what the better human studies used. Watch the sodium if you're tracking it.
Pick an amino-acid-bound form like ours if you'd rather drink it than swallow capsules, or if sodium is a concern.
And if your interest in butyrate is really about gut health generally, food does a lot of this work. Fiber feeds the bacteria that produce butyrate in the amounts your colon evolved to expect. Our pieces on gut health and GLP-1 and leaky gut and inflammation go deeper there.
Where do cravings and food noise fit into this?
Most people who email me about butyrate forms aren't actually asking a chemistry question. They're asking whether any of it will quiet the food noise at 9pm.
Fair question, so here's my honest answer. Butyrate form is a minor variable compared to whether you're eating enough fiber and protein, sleeping, and managing stress. The gut-brain signaling that shapes appetite is real and worth understanding (the gut-brain axis covers it), and it's slower and less dramatic than supplement marketing suggests.
Ozzi puts butyrate alongside allulose, glucomannan, inulin, cluster dextrin, African mango, and chromium, because appetite has more than one lever. Butyrate alone was never going to carry it.
Frequently asked questions
Is tributyrin better than sodium butyrate?
No human trial has compared them directly for any outcome. Tributyrin has a slower release profile in theory, but the one human digestion model that tested it found plain tributyrin was cleaved in the stomach compartment rather than the small intestine.
Does butyrate raise GLP-1?
In rodent and cell studies, butyrate stimulates the L-cells that release GLP-1. In the human trial that measured GLP-1 as a secondary outcome while successfully raising circulating butyrate, GLP-1 did not change.
Which butyrate form smells the least?
Tributyrin in a softgel is generally the least noticeable, since the butyrate stays bound until digestion. Raw sodium butyrate powder is the strongest. No form is odorless.
Is sodium butyrate bad for blood pressure?
The sodium in a typical serving is small relative to a normal diet, but it's a real consideration if you're on a sodium-restricted plan. Amino-acid-bound and triglyceride forms avoid it entirely.
Can I just eat fiber instead?
For most people, yes, and it's the better starting point. Your gut bacteria produce butyrate from fermentable fiber. Supplements are a supplement to that, not a replacement.
How long does butyrate take to work?
Human trials that showed changes ran for weeks to months, not days. Anyone promising a next-day effect from butyrate specifically is guessing.
Is L-lysine butyrate clinically proven?
No. There are no human randomized controlled trials on L-lysine butyrate. We chose it for formulation reasons, and I'd rather say that outright than imply evidence that doesn't exist.
Are there side effects?
Reported effects in trials were mild and infrequent, mostly transient nausea or headache. One type 2 diabetes trial noted unfavorable cholesterol shifts, which is worth discussing with your doctor if you have lipid concerns.
Should I take butyrate with food?
Tributyrin needs pancreatic lipase, which is most active during a meal containing fat, so taking it with food makes mechanistic sense. Other forms are less dependent on meal timing.
Butyrate you can actually drink
Ozzi Crave Crusher puts 500mg of L-lysine butyrate in a cold-water stick with allulose, glucomannan, inulin, and chromium. No capsules to swallow. No caffeine.
Try it for 14 days straight. If it doesn't work, we'll refund your first bag.
References
- van Deuren T, et al. Butyrate and hexanoate-enriched triglycerides increase postprandial systemic butyrate and hexanoate in men with overweight/obesity. Frontiers in Nutrition. 2023. https://doi.org/10.3389/fnut.2022.1066950 (human)
- Mitrović M, et al. Exploring the Potential of Oral Butyrate Supplementation in Metabolic Dysfunction-Associated Steatotic Liver Disease. International Journal of Molecular Sciences. 2025. https://doi.org/10.3390/ijms26125561 (human)
- de Groot PF, et al. Oral butyrate does not affect innate immunity and islet autoimmunity in individuals with longstanding type 1 diabetes. Diabetologia. 2020. https://doi.org/10.1007/s00125-019-05073-8 (human)
- Pietrzak A, et al. Sodium Butyrate Effectiveness in Children and Adolescents with Newly Diagnosed Inflammatory Bowel Diseases. Nutrients. 2022. https://doi.org/10.3390/nu14163283 (human)
- Khosravi Z, et al. The effects of butyrate supplementation on glycemic control, lipid profile, blood pressure, nitric oxide level and glutathione peroxidase activity in type 2 diabetic patients. Clinical Nutrition ESPEN. 2022. https://doi.org/10.1016/j.clnesp.2022.03.008 (human)
- Facchin S, et al. Microbiota changes induced by microencapsulated sodium butyrate in patients with inflammatory bowel disease. Neurogastroenterology & Motility. 2020. https://doi.org/10.1111/nmo.13914 (human)
- Coppola S, et al. Therapeutic Effects of Butyrate on Pediatric Obesity: A Randomized Clinical Trial. JAMA Network Open. 2022. https://doi.org/10.1001/jamanetworkopen.2022.44912 (human)
- Yang N, et al. Tributyrin alleviates gut microbiota dysbiosis to repair intestinal damage in antibiotic-treated mice. PLoS One. 2023. https://doi.org/10.1371/journal.pone.0289364 (rodent)
- Cresci GA, et al. Prophylactic tributyrin treatment mitigates chronic-binge ethanol-induced intestinal barrier and liver injury. Journal of Gastroenterology and Hepatology. 2017. https://doi.org/10.1111/jgh.13731 (rodent and in vitro)
- Siddiqui MT, et al. The Postbiotic Butyrate Mitigates Gut Mucosal Disruption Caused by Acute Ethanol Exposure. International Journal of Molecular Sciences. 2024. https://doi.org/10.3390/ijms25031665 (rodent and human cell)
- Cresci G, et al. Lactobacillus GG and tributyrin supplementation reduce antibiotic-induced intestinal injury. JPEN. 2013. https://doi.org/10.1177/0148607113486809 (rodent)
- Ullah S, et al. Comparative Effects of Dietary Supplementations with Microencapsulated Sodium Butyrate, Glycerol Monolaurate and Tributyrin. Animals. 2025. https://doi.org/10.3390/ani15060810 (fish)
Research sourced via PubMed.